Wednesday, October 7, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 10, 2025

MacLean Power Systems and Power Grid Components Join Forces to Form Leading Supplier of Engineered Components and Solutions for Utility Infrastructure

View original at finance.yahoo.com
MacLean Power Systems and Power Grid Components Join Forces to Form Leading Supplier of Engineered Components and Solutions for Utility Infrastructure Transformative merger through Blackstone investment brings together two complementary suppliers of critical equipment for the U.S…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • MacLean Power Systems investment highlights Centerbridge's longstanding thematic focus on electric grid modernization and the company delivered exceptional growth over the last three years

    80% confidence

  • MacLean Power Systems plays a vital role in supporting the safety, efficiency, and resiliency of the grid

    80% confidence

  • MacLean Power Systems is one of the leaders in the industry and together with PGC is well positioned to benefit from growing need for critical equipment that improves the safety, reliability, and efficiency of America's electrical network

    80% confidence

  • Centerbridge has been a partner to MacLean Power Systems and customers and employees have helped the company grow over the last three years

    80% confidence

  • MacLean Power Systems is a premier brand built on decades of providing reliable, high-quality, essential components for the power grid and adjacent industries with comprehensive product portfolio highly complementary to PGC's solutions

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com
MacLean Power Systems and Power Grid Components Join Forces to Form Leading Supplier of Engineered Components and Solutions for Utility Infrastructure — Source | Via News | ViaNews Market